Deep learning for developmental dysplasia of the hip: comparative classification strategies for ultrasound imaging with heterogeneous image quality.

Authors

Shota Ichikawa, Yohan Kondo

Published in

Physical and engineering sciences in medicine. Jul 14, 2026. Epub Jul 14, 2026.

Abstract

Computer-assisted diagnostic tools may help improve the consistency and reliability of ultrasonographic screening for developmental dysplasia of the hip (DDH). This study aimed to compare preprocessing strategies for convolutional neural network (CNN)-based classification of infant hip ultrasound images under heterogeneous image quality conditions. We evaluated six approaches for classifying infant hip ultrasound images as normal or abnormal: original-image CNN classification, CycleGAN-based domain translation in two directions, DeepLabV3-Plus-based segmentation preprocessing, and two combined approaches using CycleGAN followed by DeepLabV3-Plus. Each approach was independently trained and evaluated ten times using ninefold cross-validation, and performance was assessed using the area under the receiver operating characteristic curve (AUC). The baseline approach using original images achieved a mean AUC of 0.724 (95% confidence interval [CI]: 0.711-0.737). CycleGAN-based domain translation did not improve performance, with mean AUCs of 0.719 (95% CI: 0.703-0.736) for Dataset A-to-B translation and 0.679 (95% CI: 0.658-0.700) for Dataset B-to-A translation. DeepLabV3-Plus-based segmentation preprocessing showed the numerically highest mean AUC of 0.791 (95% CI: 0.773-0.809), while the combined approaches achieved mean AUCs of 0.780 and 0.783. Pairwise comparisons with Bonferroni correction showed no statistically significant differences between approaches (all adjusted p-values > 0.05). These exploratory findings suggest that segmentation-based preprocessing may be a promising strategy for CNN-based classification of infant hip ultrasound images under heterogeneous imaging conditions, whereas CycleGAN-based domain translation did not provide a measurable benefit in this setting. Further validation using larger multicenter datasets is required before clinical applicability can be established.

PMID:
42446839
Bibliographic data and abstract were imported from PubMed on 14 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.